Drug
Vensobafusp alfa clinical trials
Also written KP104.
Keep track of what changes. Save the vensobafusp alfa studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
- KP104
- 4
Studies by the year they started
4 studies that test it; most in 2025 (2)
| Year | Studies |
|---|---|
| 2020 | 1 |
| 2022 | 1 |
| 2025 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Kira Pharmacenticals (US), LLC. (4)
Studies
Open first, then newest update. How each study uses vensobafusp alfa is read from its arms, and is right about nine times in ten.
Testing it · 4
- Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of KP104 to Treat GlomerulonephritisNot yet recruitingPhase 2Kira Pharmacenticals (US), LLC.NCT05517980Written as KP104
- Study to Evaluate Safety, Tolerability and Pharmacodynamics of KP104 in Participants With Thrombotic Microangiopathy Secondary to Systemic Lupus ErythematosusNot yet recruitingPhase 2Kira Pharmacenticals (US), LLC.NCT05504187Written as KP104
- To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of KP104Active, not recruitingPhase 2Kira Pharmacenticals (US), LLC.NCT05476887Written as KP104
- To Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Escalating Single and Multiple Doses of KP104CompletedPhase 1Kira Pharmacenticals (US), LLC.NCT05490017Written as KP104
Codes
What other systems call vensobafusp alfa · ClinicalTrials.gg INT016624
- UNII (FDA) G3PS38JMS8VENSOBAFUSP ALFAOne source FDA
- NCI Thesaurus C190117Vensobafusp AlfaOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | G3PS38JMS8 | VENSOBAFUSP ALFA | One source FDA |
| NCI Thesaurus | C190117 | Vensobafusp Alfa | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.